Page 54 - JSOM Fall 2022
P. 54

outer surface and the adhesive coating on its inner surface   and “elevated” perfusion pressures as presented in Table 3.
          physically interact in a way that allows the wrap to be re­  Ease­of­use scores across all trials were similar for both tour­
          peatedly adhered to and de­bonded from itself. During appli­  niquet types and are reported in Table 4.
          cation, the ST is tightly wound around a limb two or more
          times in an application process similar to the placement of an   TABLE 4  Tourniquet Ease-of-Use Scores
            Esmarch tourniquet. Next, the ST is tightened to the desired   Scored Response to Statement,
          level of limb compression by application of additional wraps   “Tourniquet was easy to apply.”  ST  CAT
          while under user­applied, pull tension. Once hands­free hem­  4 ­ Strongly agree  17 (71%)  19 (79%)
          orrhage control is achieved, any remaining unused length of   3 ­ Somewhat agree  6 (25%)  3 (13%)
          the adhesive self­secured ST can be left intact or removed if de­  2 ­ Neutral  1 (4%)     2 (8%)
          sired. Post­application, the ST is adjusted by peeling back the   1 ­ Somewhat disagree  0   0
          free end from the limb and unwinding a portion of the wrap   0 ­ Strongly disagree  0        0
          before rewinding it around the limb under modified tension   Pooled self­reported user scores from each tourniquet trial.
          until the desired compression is achieved.
                                                             Tourniquet Completion Pressure
          Statistical Analysis                               As shown in Table 3, the mean tourniquet pressure immedi­
          The mean, standard deviation, and standard error for each per­  ately following completed application was found to be > 40%
          formance metric as well as the calibration curve for pressure   lower for the ST than for the CAT under both “normal” and
          transducer readings were calculated using Microsoft Excel for   “elevated” arterial perfusion pressures with statistical signif­
          Microsoft 365 (Microsoft Corporation, Redmond, WA, USA).   icance (p < .05). It should be noted that a positioning error
          Additional statistical computations were performed using the   which compromised the collection of pressure readings from
          permuter R package (version 0.1.0, https://github.com/statlab/  both cuffs was discovered and corrected by an independent
          permuter) and the R language and environment for statistical   member of the laboratory support staff prior to the eighth
          computing and graphics (version 4.0.5, www.r­project.org). For   tourniquet trial conducted at “normal” perfusion pump pres­
          each tourniquet performance metric, evidence for the null hy­  sures. As a result, tourniquet pressure measurements obtained
          pothesis of no difference in means between the two devices was   during the first four CAT trials and the first three ST trials
          assessed against an alternative hypothesis of (non­directional)   under “normal” perfusion parameters were excluded from the
          inequality. A difference­in­means test statistic (two­sample    data analysis described herein and presented in Table 3. The
          t­statistic with pooled variance) was used to examine perfor­  pressure sensor issue did not impact or result in the exclusion
          mance metrics between the two tourniquets, with a permuta­  of any other experimental data points collected during the first
          tion test used to generate a null distribution by shuffling the   seven tourniquet trials.
          tourniquet identities 10,000 times while stratifying over tourni­
          quet users. This resulted in an exact test, using the permutation
          distributions to derive the reported p­values. Significance of all   Discussion
          p­values was assessed against the standard cutoff of p = .05.  Tourniquet Completion Pressures
                                                             The most significant finding of this laboratory study was that
                                                             the 10.2 cm wide, minimally elastic, adhesive wrap–based ST
          Results
                                                             can provide rapid and effective hemorrhage control perfor­
          Time to Achieve Arterial Occlusion                 mance at tourniquet application completion pressures sub­
          Success rates for achieving arterial occlusion were identical   stantially lower than the 3.8­cm­wide, windlass­based CAT.
          for  the  CAT  and  ST  tourniquets  at  both  the  “normal”  and   While other studies of the ST have not been published to­date,
          “elevated” arterial perfusion pressure regimens used. As sum­  previous studies of the CAT conducted on healthy, adult hu­
          marized in Table 3, the mean time to achieve arterial occlusion   man volunteers and which used similar pressure monitoring
          was similar between the two tourniquet types for both sets of   systems reported mid­thigh, tourniquet completion pressures
          perfusion parameters.                              that corroborate the CAT completion pressures measured in
                                                             this  cadaver  study. 16,33   As  a  result,  our  research  finding  has
          Time to Complete Tourniquet Application            significant patient safety implications since a leading concern
          The mean time required to complete tourniquet application   surrounding the use of tourniquets is the risk of permanent
          was nearly identical between the CAT and ST under “normal”   nerve and soft tissue damage resulting from high, sustained

          TABLE 3  Tourniquet Performance
                                                ST         CAT                   ST         CAT
                                                  146 ± 29mmHg Perfusion            471 ± 3mmHg Perfusion
          Tourniquet                                (“Normal” Pressure)              (“Elevated” Pressure)
          Success, n (%)                      20 (100)    20 (100)             4 (100)     4 (100)
          Time to achieve occlusion, s
              Mean ± SE                       25 ± 2      22 ± 2     p = .23   24 ± 7      24 ± 7     p = .94
              Median, Minimum, Maximum       22, 15, 51  20, 13, 37           23, 10, 40   21, 12, 42
          Time to complete application, s
              Mean ± SE                       27 ± 2      26 ± 2     p = .56   25 ± 7      25 ± 7     p = .91
              Median, Minimum, Maximum       23, 16, 52  22, 16, 42           24, 11, 41  21, 13, 43
          Pressure at completion, mmHg
              Mean ± SE                      110 ± 20    210 ± 30   p = .009   190 ± 50    340 ± 30   p = .03
              Median, Minimum, Maximum      77, 31, 315  188, 44, 420        207, 51, 309  367, 257, 383
          SE = standard error


          52  |  JSOM   Volume 22, Edition 3 / Fall 2022
   49   50   51   52   53   54   55   56   57   58   59